About Getreal Initiative
Launched in June 2018 and will run until the end of April 2021, the GetReal Initiative is a project of the Innovative Medicines Initiative (IMI), a EU public-private consortium consisting of pharmaceutical companies, academia, HTA agencies and regulators, patient organisations and SMEs. The ultimate goal is to drive the adoption of tools, methodologies and best practices from IMI GetReal and increase the quality of real-world evidence (RWE) generation in medicines development and regulatory/HTA processes across Europe. The work of the GetReal project will be continued in the GetReal Institute, a sustainable platform to further the development and use of RWE methods.
Achievements of GetReal
The GetReal Initiative project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 807012. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.